Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
BioXcel Clinical Research Site, Anaheim, California Bioxcel Clinical Research Site, Hialeah, Florida BioXcel Clinical Research Site, Atlanta, Georgia Bioxcel Clinical Research Site, Decatur, Georgia BioXcel Clinical Research Site, DeSoto, Texas